COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 1793: Articles 17921-17930  | Next

Multi-objective Risk-based Resource Allocation for Urban Pandemic Preparedness: The COVID-19 Case in Bogota, Colombia
Prieto, J., Gomez, J.
10.1101/2021.02.24.21252407 — Posted: 2021-03-01
A novel 5E training model and other methods implemented for rapid readiness at an ad-hoc COVID-19 facility in India
Singh, S., Singh, A. R., Pathak, B., Tilak, T., Kumar, A., Bhatia, I., Hasvi, J.
10.1101/2021.02.23.21251976 — Posted: 2021-03-01
COVID-19 Vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-methods study
Dereje, N., Tesfaye, A., Tamene, B., Alemshet, D., Abe, H., Tesfa, N., Gedion, S., Biruk, T., Lakew, Y.
10.1101/2021.02.25.21252443 — Posted: 2021-03-01
HYPER: Group testing via hypergraph factorization applied to COVID-19
Hong, D., Dey, R., Lin, X., Cleary, B., Dobriban, E.
10.1101/2021.02.24.21252394 — Posted: 2021-03-01
Graphical Models of Pandemic
Chertkov, M., Abrams, R., Esmaieeli Sikaroudi, A. M., Krechetov, M., Slagle, C. N., Efrat, A., Fulek, R., Oren, E.
10.1101/2021.02.24.21252390 — Posted: 2021-03-01
Leveraging genetic data to elucidate the relationship between Covid-19 and ischemic stroke
Zuber, V., Cameron, A., Myserlis, E. P., Bottolo, L., Fernandez-Cadenas, I., Burgess, S., Anderson, C. D., Dawson, J., Gill, D.
10.1101/2021.02.25.21252441 — Posted: 2021-03-01
Synthetic protein antigens for COVID-19 diagnostics
Schein, C. H., McClellan, S. F., Levine, C. B., Negi, S. S., Braun, W., Dreskin, S., Anaya, E. S., Schmidt, J.
10.1101/2021.02.23.21251934 — Posted: 2021-03-01
Remdesivir as a tool to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
BERAUD, G., Timsit, J.-F., Leleu, H.
10.1101/2021.02.24.21252355 — Posted: 2021-03-01
A precise score for the regular monitoring of COVID-19 patients condition validated within the first two waves of the pandemic
Bakin, E. A., Stanevich, O. V., Belash, V. A., Belash, A. A., Sayenko, L. F., Korobenkov, E. A., Lioznov, D. A., Polushin, Y. S., Kulikov, A. N.
10.1101/2021.02.09.21249859 — Posted: 2021-03-01
Interpreting vaccine efficacy trial results for infection and transmission
Lipsitch, M., Kahn, R.
10.1101/2021.02.25.21252415 — Posted: 2021-02-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).